ceocfonewsline.com
Cannabinoid-based Therapeutics, Nemus Bioscience
26, 2018 Issue. Nemus Bioscience is developing Bio-engineered Medicines using Cannabinoid Molecules in a Pro-drug of THC to offer a Revolutionary Treatment for Glaucoma Patients with a Dual Benefit of Lowering Intraocular Pressure and Providing Neuroprotection. Dr Brian Murphy, MD, MPH, MBA. Chief Executive Officer; Chief Medical Officer, Director. Http:/ www.nemusbioscience.com/home/default.aspx. Bud Wayne, Editorial Executive, CEOCFO Magazine, Published February 26, 2018. Cannabinoid-based therapies ar...
ceocfonotes.com
Private High schools, Fusion Education Group
12, 2018 Issue. Q&A with Peter G. Ruppert, President and CEO of Fusion Education Group and their chain of 43 Fusion Academy flagship private schools providing Customized, One-to-One Education enabling Greater Student Success. Peter G. Ruppert. President and Chief Executive Officer. Lynn Fosse, Senior Editor, CEOCFO Magazine, Published February 12, 2018. CEOCFO: Mr. Ruppert, what is the concept behind Fusion Education Group? CEOCFO: How do you go about recognizing what is best for any given child? CEOCFO:...
ceocfoonline.com
Automating Healthcare Communications and Payments, Intelligent Contacts
5, 2018 Issue. Q&A with Jeff Mains, CEO of Intelligent Contacts automating the Communications and Payment process for Healthcare Providers and Improving the Customer Experience for Patients. Lynn Fosse, Senior Editor, CEOCFO Magazine, Published February 5, 2018. Mr Mains, what is the concept behind Intelligent Contacts? Found that 96% of physician complaints relate to poor communications and customer service, and only 4% were actually about the quality of care. We have a payment IVR, so someone can call ...
ceocfoonwallstreet.com
Domain Default page
If you are seeing this message, the website for is not available at this time. If you are the owner of this website, one of the following things may be occurring:. You have not put any content on your website. Your provider has suspended this page. Please login to to receive instructions on setting up your website. This website was created using our Parallels Plesk product. We offer a full line of Billing, Sitebuilder and cloud computing tools. Please visit www.parallels.com. To find out more information.
ceocfopost.com
Treatment for Traumatic Brain Injury, Helius Medical Technologies, Inc.
Helius Medical Technologies, Inc. 4, 2017 Issue. Q&A with Philippe Deschamps, President, Chairman and CEO of Helius Medical Technologies, Inc. releasing Registrational Trial Data for their Portable Neuromodulation Stimulator, PoNS Device showing ability to help Patients Recover from Balance Disorder caused by Traumatic Brain Injury. President, Chairman and CEO. Helius Medical Technologies, Inc. TSX: HSM) (OTC: HSDT). Lynn Fosse, Senior Editor, CEOCFO Magazine, Published December 4, 2017. Are there curren...
ceocfopublication.com
Health Care Scheduling Software, Potentia Analytics, Inc.
Potentia Analytics, Inc. 4, 2017 Issue. Q&A with Berardino E. Baratta, CEO of Potentia Analytics, Inc. a leading provider of advanced workforce and workflow optimization solutions for healthcare including Intelligent Provider Scheduling, ER Patient Flow Optimization and a Policy and Decision-making module. Berardino E. Baratta. Potentia Analytics, Inc. Lynn Fosse, Senior Editor, CEOCFO Magazine, Published December 4, 2017. CEOCFO: What did they come up with? What is the product or service? The customer w...
ceocforeporter.com
Health Care Scheduling Software, Potentia Analytics, Inc.
Potentia Analytics, Inc. 4, 2017 Issue. Q&A with Berardino E. Baratta, CEO of Potentia Analytics, Inc. a leading provider of advanced workforce and workflow optimization solutions for healthcare including Intelligent Provider Scheduling, ER Patient Flow Optimization and a Policy and Decision-making module. Berardino E. Baratta. Potentia Analytics, Inc. Lynn Fosse, Senior Editor, CEOCFO Magazine, Published December 4, 2017. CEOCFO: What did they come up with? What is the product or service? The customer w...
ceocforeports.com
Myelodysplastic Syndrome Treatment, Onconova Therapeutics
Onconova Therapeutics (Nasdaq: ONTX). 23, 2017 Issue. With their drug Rigosertib now in Phase III Trials for the Bone Marrow Disorder Myelodysplastic Syndrome used in over 500 Patients, Onconova Therapeutics brings hope to many Elderly Suffering from this Devastating Disease. Dr Ramesh Kumar, PhD. Onconova Therapeutics (Nasdaq: ONTX). Bud Wayne, Editorial Executive, CEOCFO Magazine, Published October 23, 2017. The fact that we were able to go from the invention of the molecule through the toxicology, thr...
ceocforeviews.com
Intelligence Management System, AI Foundry
November 13, 2017 Issue. Q&A with Steve Butler, General Manager of AI Foundry,. Kodak Alaris business unit providing Enterprise Software with Automation and Actionable Intelligence to the. Document Intensive Businesses in the Financial and Insurance Industries and the Public Sector. Lynn Fosse, Senior Editor, CEOCFO Magazine, Published November 13, 2017. Mr Butler, what is the vision behind AI Foundry? CEOCFO: How do you provide actionable intelligence management solutions? We have very aggressive plans ...
ceocfostockexchange.com
Domain Default page
If you are seeing this message, the website for is not available at this time. If you are the owner of this website, one of the following things may be occurring:. You have not put any content on your website. Your provider has suspended this page. Please login to to receive instructions on setting up your website. This website was created using our Parallels Plesk product. We offer a full line of Billing, Sitebuilder and cloud computing tools. Please visit www.parallels.com. To find out more information.
ceocfostocknews.com
Domain Default page
If you are seeing this message, the website for is not available at this time. If you are the owner of this website, one of the following things may be occurring:. You have not put any content on your website. Your provider has suspended this page. Please login to to receive instructions on setting up your website. This website was created using our Parallels Plesk product. We offer a full line of Billing, Sitebuilder and cloud computing tools. Please visit www.parallels.com. To find out more information.
SOCIAL ENGAGEMENT